Regulus Therapeutics Inc (RGLS) — Cash Flow Reinvestment Rate
Regulus Therapeutics Inc (RGLS) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting $237.00K (capex $237.00K ) from operating cash flow of $3.19 Million. Explore cash efficiency ratio of Regulus Therapeutics Inc to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regulus Therapeutics Inc Cash Flow Reinvestment Rate (2010–2010)
Historical reinvestment intensity for Regulus Therapeutics Inc across 1 annual periods. Explore how much of Regulus Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Regulus Therapeutics Inc (2010–2010)
Year-by-year capital reinvestment analysis for Regulus Therapeutics Inc. For live market cap and broader valuation context, see market value of Regulus Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | $2.42 Million | $12.31 Million | $2.42 Million | — |